Sensex Crosses 60,000 Mark for First Time in More Than 4 Months
India’s stock market benchmark opened in the green on Wednesday, with the Sensex breaking the 60,000-point mark in intraday trading for the first time since...
Tag : Cipla
Sensex Up 200 Points, Nifty50 Tops 17,400 Ahead of RBI Policy Announcement
The Indian equity benchmark opened in the green on the last trading day of the trading week ahead of the Reserve Bank of India’s key...
Cipla To Invest Rs 26 Crore in GoApptiv to Raise Stake to 22%
Pharmaceutical company Cipla has agreed to buy an additional stake in digital tech firm GoApptiv Private for nearly Rs 26 crore, raising its stake to...
Cipla to Acquire 21% Stake in Achira Labs for Rs 25 Crore
Pharmaceutical giant Cipla Ltd said on Friday it would buy a 21.05% stake in Achira Labs Pvt Ltd, which develops and commercialises point-of-care (POC) medical...
Cipla Signs Deal with Genes2Me to Launch COVID-19 RT PCR Test Kit
On Tuesday, pharmaceutical giant Cipla said it has partnered with diagnostics firm Genes2Me to launch a COVID-19 RT PCR test kit in the country. In...
Cipla Gets DGCI Permission to Import Moderna’s Vaccine
Cipla, a multinational pharmaceutical company headquartered in Mumbai, on Tuesday received approval from the Drugs Controller General of India (DCGI) to import Moderna’s coronavirus vaccine...
Nifty Pharma Climbs 3% After RBI Announces Liquidity
Nifty Pharma stocks were in fast lane on Wednesday tracking all market clues. The performance in pharma stocks comes after when the RBI Governor Shaktikanta...
Cipla Partners Premier Medical Corporation to Launch CIP Test Kits in India
Cipla announced its partnership with the Premier Medical Corporation for the commercialization of the rapid antigen test kits for COVID-19 in India. The company will commence...
Cipla Outlook for the Week (July 27,2020 – July 31, 2020)
EquityPandit’s Outlook for Cipla for the week (July 27,2020 – July 31, 2020): CIPLA: BSE: 500087| NSE: CIPLA| ISIN: INE059A01026| SECTOR: PHARMA Stock closed the week...
Mylan to Manufacture DESREMTM in Bengaluru
The global pharmaceutical company has revealed that DESREMTM will be available to patients at 4,800 per 100 mg vial.On Monday, Mylan announced the commercial launch of its...